Towards the development of human immune-system-on-a-chip platforms

Alessandro Polini, Loretta L. del Mercato, Adriano Barra, Yu Shrike Zhang, Franco Calabi, Giuseppe Gigli

View at source ↗PDF ↗Article99 citations

Abstract

Organ-on-a-chip (OoCs) platforms could revolutionize drug discovery and might ultimately become essential tools for precision therapy. Although many single-organ and interconnected systems have been described, the immune system has been comparatively neglected, despite its pervasive role in the body and the trend towards newer therapeutic products (i.e., complex biologics, nanoparticles, immune checkpoint inhibitors, and engineered T cells) that often cause, or are based on, immune reactions. In this review, we recapitulate some distinctive features of the immune system before reviewing microfluidic devices that mimic lymphoid organs or other organs and/or tissues with an integrated immune system component.

Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.

Record

Archive ID
arxiv:2102.13174
Published
Feb 25, 2021
Venue
Drug Discovery Today, 2019
DOI
10.1016/j.drudis.2018.10.003
arXiv
2102.13174
Categories
physics.bio-ph, physics.app-ph, q-bio.CB
Provenance
arxiv

Topics